System Guide
Back to Search Results

Search Results

Display Options
Display Options
Select Fields
Export Results to CSV Create Report 0
+ Add all results to report

Report Produced: 12/22/2025 05:57 AM

Report Question ID Question
20180047

Reportability--Kidney: Is a hybrid oncocytic tumor reportable? See Discussion.
20230053

Reportability/Histology--Ovary/Testis: Is serous borderline tumor-micropapillary variant (8460/2) of the ovary or testis reportable? If so, what dates are applicable to the reportability changes?  See Discussion.
20230036

Reportability/Histology--Vulva:  Is angiomyxoma (8841/1), such as aggressive angiomyxoma of vulva diagnosed in 2022, reportable?
20250002 Reportability/Histology--Soft Tissue: Is superficial CD34 positive fibroblastic tumor reportable and if so what histology code should be used? See Discussion.  
20150047

Reportability--Bladder: Is a positive UroVysion test alone diagnostic of bladder cancer? See discussion.

20220005

Reportability--Ambiguous Terminology:  Can the term “at most” preceding a statement of a reportable diagnosis be used to accession a case? See Discussion.
20091021

Behavior/Reportability--All sites: Would a GIST tumor stated to be "high risk for malignant behavior" be a reportable GIST? See Discussion.
20230050

Reportability/Histology--Soft Tissue: Is a diagnosis of Myofibroblastoma with sarcomatous transformation a reportable malignancy?  See Discussion.
20180081

Reportability--Corpus uteri: Is endometrial atypical complex hyperplasia/borderline endometrial adenocarcinoma (FIGO 1), (mucinous type), (no invasion of myometrium) reportable?
20240078

Reportability/Histology--Lung: Are adenocarcinoma spectrum lesions on lung imaging reportable when no further information is available? See Discussion.